Werlenius O - Search Results

1

Evaluation of clinical staging in chronic lymphocytic leukemia- population-based study.

Apelgren P, Hasselblom S, Werlenius O, Nilsson-Ehle H, Andersson PO; Western Sweden Lymphoma Group. Apelgren P, et al. Among authors: werlenius o. Leuk Lymphoma. 2006 Dec;47(12):2505-16. doi: 10.1080/10428190600881322. Leuk Lymphoma. 2006. PMID: 17169795

2

The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL).

Junevik K, Werlenius O, Hasselblom S, Jacobsson S, Nilsson-Ehle H, Andersson PO. Junevik K, et al. Among authors: werlenius o. Ann Hematol. 2007 Feb;86(2):89-94. doi: 10.1007/s00277-006-0198-x. Epub 2006 Oct 17. Ann Hematol. 2007. PMID: 17043777

3

Tumour-loaded α-type 1-polarized dendritic cells from patients with chronic lymphocytic leukaemia produce a superior NK-, NKT- and CD8+ T cell-attracting chemokine profile.

Gustafsson K, Junevik K, Werlenius O, Holmgren S, Karlsson-Parra A, Andersson PO. Gustafsson K, et al. Among authors: werlenius o. Scand J Immunol. 2011 Sep;74(3):318-326. doi: 10.1111/j.1365-3083.2011.02580.x. Scand J Immunol. 2011. PMID: 21595737 Free article.

4

Improved outcome for very elderly patients with diffuse large B-cell lymphoma in the immunochemotherapy era.

Hasselblom S, Stenson M, Werlenius O, Sender M, Lewerin C, Hansson U, Nilsson-Ehle H, Andersson PO. Hasselblom S, et al. Among authors: werlenius o. Leuk Lymphoma. 2012 Mar;53(3):394-9. doi: 10.3109/10428194.2011.616612. Epub 2011 Oct 10. Leuk Lymphoma. 2012. PMID: 21864039

5

High functional CD70 expression on α-type 1-polarized dendritic cells from patients with chronic lymphocytic leukaemia.

Junevik K, Werlenius O, Fogelstrand L, Karlsson-Parra A, Andersson PO. Junevik K, et al. Among authors: werlenius o. Scand J Immunol. 2014 Jun;79(6):415-22. doi: 10.1111/sji.12172. Scand J Immunol. 2014. PMID: 24684541 Free article.

6

Reactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cells.

Werlenius O, Aurelius J, Hallner A, Akhiani AA, Simpanen M, Martner A, Andersson PO, Hellstrand K, Thorén FB. Werlenius O, et al. Oncotarget. 2016 May 31;7(22):32046-53. doi: 10.18632/oncotarget.8769. Oncotarget. 2016. PMID: 27097113 Free PMC article.

7

Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population.

Wedge E, Hansen JW, Dybedal I, Creignou M, Ejerblad E, Lorenz F, Werlenius O, Ungerstedt J, Holm MS, Nilsson L, Kittang AO, Antunovic P, Rohon P, Andersen MK, Papaemmanuil E, Bernard E, Jädersten M, Hellström-Lindberg E, Grønbæk K, Ljungman P, Friis LS. Wedge E, et al. Among authors: werlenius o. Transplant Cell Ther. 2021 Dec;27(12):991.e1-991.e9. doi: 10.1016/j.jtct.2021.08.028. Epub 2021 Sep 6. Transplant Cell Ther. 2021. PMID: 34500124 Free article.

8

Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.

Bernson E, Hallner A, Sander FE, Wilsson O, Werlenius O, Rydström A, Kiffin R, Brune M, Foà R, Aurelius J, Martner A, Hellstrand K, Thorén FB. Bernson E, et al. Among authors: werlenius o. Leukemia. 2017 Dec;31(12):2552-2559. doi: 10.1038/leu.2017.151. Epub 2017 May 22. Leukemia. 2017. PMID: 28529313 Free PMC article.

9

Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species.

Akhiani AA, Hallner A, Kiffin R, Aydin E, Werlenius O, Aurelius J, Martner A, Thorén FB, Hellstrand K. Akhiani AA, et al. Among authors: werlenius o. Cancer Immunol Res. 2020 Dec;8(12):1532-1541. doi: 10.1158/2326-6066.CIR-20-0055. Epub 2020 Sep 23. Cancer Immunol Res. 2020. PMID: 32967913

10

NOX2-dependent immunosuppression in chronic myelomonocytic leukemia.

Aurelius J, Hallner A, Werlenius O, Riise R, Möllgård L, Brune M, Hansson M, Martner A, Thorén FB, Hellstrand K. Aurelius J, et al. Among authors: werlenius o. J Leukoc Biol. 2017 Aug;102(2):459-466. doi: 10.1189/jlb.5VMA1116-454R. Epub 2017 Mar 14. J Leukoc Biol. 2017. PMID: 28292946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters